Cargando…
Review of the Novel Investigational Antifungal Olorofim
The incidence of invasive fungal infections caused by molds and endemic fungi is increasing. There is also concern regarding increased rates of reduced susceptibility or frank resistance among Aspergillus and Coccidioides species, while Scedosporium species, Lomentospora prolificans, and Fusarium sp...
Autor principal: | Wiederhold, Nathan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557671/ https://www.ncbi.nlm.nih.gov/pubmed/32751765 http://dx.doi.org/10.3390/jof6030122 |
Ejemplares similares
-
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021) -
In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans
por: Georgacopoulos, Ourania, et al.
Publicado: (2023) -
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
por: Georgacopoulos, Ourania, et al.
Publicado: (2021) -
In vitro activity of the novel antifungal olorofim against dermatophytes and opportunistic moulds including Penicillium and Talaromyces species
por: Singh, Ashutosh, et al.
Publicado: (2021) -
Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance
por: Buil, Jochem B., et al.
Publicado: (2022)